Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Research priorities in Maternal, Newborn, & Child Health & Nutrition for India: An Indian Council of Medical Research-INCLEN Initiative.
Arora NK, Swaminathan S, Mohapatra A, Gopalan HS, Katoch VM, Bhan MK, Rasaily R, Shekhar C, Thavaraj V, Roy M, Das MK, Wazny K, Kumar R, Khera A, Bhatla N, Jain V, Laxmaiah A, Nair MKC, Paul VK, Ramachandran P, Ramji S, Vaidya U, Verma IC, Shah D, Bahl R, Qazi S, Rudan I, Black RE; ICMR INCLEN Research Priority Setting Network; National Steering Group; Research Sub-Committee; Nation-wide Network. Arora NK, et al. Indian J Med Res. 2017 May;145(5):611-622. doi: 10.4103/ijmr.IJMR_139_17. Indian J Med Res. 2017. PMID: 28948951 Free PMC article.
Prevalence of long COVID symptoms in Haryana, India: a cross-sectional follow-up study.
Chaudhry D, Khandelwal S, Bahadur C, Daniels B, Bhattacharyya M, Gangakhedkar R, Desai S, Das J; Long COVID India study group. Chaudhry D, et al. Lancet Reg Health Southeast Asia. 2024 Mar 29;25:100395. doi: 10.1016/j.lansea.2024.100395. eCollection 2024 Jun. Lancet Reg Health Southeast Asia. 2024. PMID: 38586062 Free PMC article.
Comparison of the immunogenicity and safety of Euvichol-Plus with Shanchol in healthy Indian adults and children: an open-label, randomised, multicentre, non-inferiority, parallel-group, phase 3 trial.
Shah S, Nandy RK, Sethi SS, Chavan B, Pathak S, Dutta S, Rai S, Singh C, Chayal V, Patel C, Kumar NR, Chavan AT, Chawla A, Singh A, Roy AK, Singh N, Baik YO, Lee Y, Park Y, Jeong KH, Ahmed S. Shah S, et al. Among authors: chayal v. Lancet Reg Health Southeast Asia. 2023 Aug 24;19:100256. doi: 10.1016/j.lansea.2023.100256. eCollection 2023 Dec. Lancet Reg Health Southeast Asia. 2023. PMID: 38076719 Free PMC article.